Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
about
Sustained activation of SMAD3/SMAD4 by FOXM1 promotes TGF-β-dependent cancer metastasisEpithelial-Mesenchymal Transition (EMT) and Regulation of EMT Factors by Steroid Nuclear Receptors in Breast Cancer: A Review and in Silico InvestigationRegulation of Bim in Health and DiseaseThe network of pluripotency, epithelial-mesenchymal transition, and prognosis of breast cancerRUNX2 and the PI3K/AKT axis reciprocal activation as a driving force for tumor progressionThe Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and TreatmentPersistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinomaWnt signaling in triple negative breast cancer is associated with metastasisRUNX2 correlates with subtype-specific breast cancer in a human tissue microarray, and ectopic expression of Runx2 perturbs differentiation in the mouse mammary gland.Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.Differences in the transcriptional response to fulvestrant and estrogen deprivation in ER-positive breast cancerRunx2 is a novel regulator of mammary epithelial cell fate in development and breast cancerMeta-analysis of gene expression signatures defining the epithelial to mesenchymal transition during cancer progressionCadherin 6 is a new RUNX2 target in TGF-β signalling pathwayThe cancer gene WWOX behaves as an inhibitor of SMAD3 transcriptional activity via direct bindingRUNX1, a transcription factor mutated in breast cancer, controls the fate of ER-positive mammary luminal cells.MiR-203 downregulation is responsible for chemoresistance in human glioblastoma by promoting epithelial-mesenchymal transition via SNAI2Genome-wide Runx2 occupancy in prostate cancer cells suggests a role in regulating secretion.Runx2 contributes to the regenerative potential of the mammary epithelium.Overexpression of runt-related transcription factor-2 is associated with advanced tumor progression and poor prognosis in epithelial ovarian cancerRUNX2 and TAZ-dependent signaling pathways regulate soluble E-Cadherin levels and tumorsphere formation in breast cancer cells.miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cellsDetection of RUNX2 gene expression in cumulus cells in women undergoing controlled ovarian stimulation.RUNX1 prevents oestrogen-mediated AXIN1 suppression and β-catenin activation in ER-positive breast cancer.The RUNX2 Transcription Factor Negatively Regulates SIRT6 Expression to Alter Glucose Metabolism in Breast Cancer CellsHeparanase promotes myeloma progression by inducing mesenchymal features and motility of myeloma cellsLong noncoding RNA GAPLINC promotes invasion in colorectal cancer by targeting SNAI2 through binding with PSF and NONO.Runx2 activates PI3K/Akt signaling via mTORC2 regulation in invasive breast cancer cells.Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.The Expression and Functional Significance of Runx2 in Hepatocellular Carcinoma: Its Role in Vasculogenic Mimicry and Epithelial-Mesenchymal Transition.The RUNX family in breast cancer: relationships with estrogen signaling.RUNX2 in mammary gland development and breast cancer.RUNX family: Regulation and diversification of roles through interacting proteins.The RUNX family: developmental regulators in cancer.Analyzing the differentially expressed genes and pathway cross-talk in aggressive breast cancer.Hormone-sensing mammary epithelial progenitors: emerging identity and hormonal regulation.Runx2-I is an Early Regulator of Epithelial-Mesenchymal Cell Transition in the Chick Embryo.Relationship between RUNX1 and AXIN1 in ER-negative versus ER-positive Breast Cancer.The Emerging Roles of RUNX Transcription Factors in Epithelial-Mesenchymal Transition.MicroRNA-23b is an independent prognostic marker and suppresses ovarian cancer progression by targeting runt-related transcription factor-2.
P2860
Q24613046-BDE1BC64-68E9-47B9-B969-86660FC0FE73Q26770051-586B89F1-05A4-4D1B-9C11-DB15610C1CC6Q26781203-46F261BE-BA6D-4AC4-8082-EE4BE43B5960Q26785448-49F605A6-D8FF-41B5-8F9F-2904A128B2A7Q26800112-665051C3-619B-457B-8D89-BC76BF89E114Q26865458-7565A44D-5413-4035-82AD-DB43F7296AC6Q27012236-0F6218AD-A096-494C-ACC0-689EB86FAFAEQ30597238-1A2105D4-B555-4E80-9FF6-AAD072DF3315Q33555996-7A1683F9-188F-4749-8EDC-7A7FC8D23AC1Q33732391-8F47733E-4EFE-482A-A83E-F369286680B6Q33993400-D1470C2C-0E84-4A62-ABE8-0309455857ADQ34258504-0AF65E1C-B246-4BBB-8EDB-7E7CC98F9ADDQ34516160-936DFF2E-C153-4725-9DAA-670E284B3DCCQ34999638-17642DCE-7605-43EC-9D4D-F9463E671F77Q35065263-DE1F0622-86D7-4BC8-A16B-CF1BB7FFD123Q35240492-E604A8EC-B2B6-4313-AC10-FFFDCEC7EA39Q35832262-7AB2E566-2001-479C-8B81-E4A830451730Q35906122-24E7219F-D91C-4DA5-A114-61A614F67CDFQ36189136-129E2DD2-19F2-4E21-A062-1294E1212387Q36329328-367ACCD4-D35C-403B-86F3-3BBA2B4FEA15Q36413997-54AF3ABE-52A6-4558-A265-15B1EF6937F0Q36451980-5007FB66-0935-462F-B3EC-71CF78415336Q36454634-12952E49-4620-45CA-87B5-424880899C99Q36637143-7C0ABE7D-37A4-4FC0-A007-F33525A9385EQ36947310-AC2B00B9-E6FC-47EC-807B-498D2334BDD6Q36998235-D263EC28-1A8E-4E7B-9560-36CE23C1A9ADQ37520492-0072A11D-BAED-4CE0-B9B4-3CB1C62DAE6FQ37691008-C8F90F55-3B1F-465E-AD4F-501EF96539EDQ37694746-6ED2FF09-C6A6-41B1-A235-49100B200A97Q37729026-6F3FFE11-0D26-452D-8D15-0D38BF1DCC6DQ38050410-077EF294-ACCC-4FF2-A673-83073ABBA805Q38061373-81D865A8-0E84-4E16-BBB6-FFB87C870171Q38062515-5EFDD61E-A214-43F2-89C8-862B6F630E82Q38319972-19FB4693-BD58-40D9-9334-8F99F32CF215Q38472495-F6A3F043-90E6-4A95-B36B-DC578D500D77Q38590446-96D924FE-BB5A-40A4-A153-BBBC3465B2D7Q38717913-01182DB4-2326-4B11-AFFA-451B8AF610DFQ38722836-DF396136-1E65-40F8-ABBA-112F2E5F56B0Q38744455-8A11D373-1D13-42F8-8212-4EE5857C18D1Q39016879-3732D4BB-7330-4AEB-ABA0-83E4EC54A4F2
P2860
Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@ast
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@en
type
label
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@ast
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@en
prefLabel
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@ast
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@en
P2093
P2860
P356
P1476
Regulation of breast cancer me ...... signaling: the role of SNAI2.
@en
P2093
Baruch Frenkel
Debu Tripathy
Gillian H Little
Michael Kahn
Nyam-Osor Chimge
Sanjeev K Baniwal
Yi-bu Chen
P2860
P2888
P356
10.1186/BCR3073
P50
P577
2011-12-09T00:00:00Z
P5875
P6179
1025090942